lipoprotein concentration of 20 Ag/ml. A maximum of approximately 250,000 molecules could be bound to each cell. Whole serum and very-low-density lipoproteins displaced laI5labeled low-density lipoproteins from the binding sites, but high-density lipoproteins, the lipoprotein-deficient fraction of serum, and abetalipoproteinemic serum did not. This binding appears to be a required step in the process by which low-density lipoproteins normally suppress the synthesis of 3-hydroxy-3-methylglutaryl coenzyme A reductase, the rate-controlling enzyme in cholesterol biosynthesis. The demonstration of a defect in binding of low-density lipoproteins to cells from subjects with the homozygous form of familial hypercholesterolemia appears to explain the previously reported failure of lipoproteins to suppress the synthesis of this enzyme and hence may account for the overproduction of cholesterol that occurs in these cultured cells.
In fibroblasts cultured from normal human subjects, the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG CoA reductase) [mevalonate: NADP+ oxidoreductase (CoA-acylating) EC 1.1.1.34], the rate-controlling enzyme in cholesterol biosynthesis, is regulated by the content of low-density lipoproteins (LDL) and very-low-density lipoproteins (VLDL) in the culture medium (1) . In cells from subjects with the homozygous form of familial hypercholesterolemia (FH), an autosomal dominant disorder characterized clinically by hypercholesterolemia, xanthomas, and premature atherosclerosis (2) , the synthesis of HMG CoA reductase molecules fails to be suppressed normally by LDL and VLDL (3, 4) . Consequently, these mutant cells overproduce cholesterol (3) . Our previous data suggested that this genetically-determined defect in enzyme regulation was due to an abnormality not in the structure of HMG CoA reductase itself but rather in a hitherto unidentified process involving the interaction of these mutant cells with extracellular lipoproteins (3, 4) .
In the present studies we have investigated the interaction Cells. Skin biopsies were obtained with informed consent, and fibroblast cultures were established in our laboratory as previously described (3) (4) (5) . Clinical data on subjects from whom these cell lines were derived are given in Table 1 of this paper and Lipoproteins. Human VLDL (d < 1.006 g/ml), LDL (d 1.019-1063 g/ml), HDL (d 1.063-1.215 g/ml), and lipoprotein-deficient serum (d > 1.215 g/ml) were isolated by sequential flotation in a Beckman preparative ultracentrifuge according to standard techniques (7) using solid KBr for density adjustment (8) . Isolated fractions were dialyzed extensively against buffer containing 20 mM Tris HC1 (pH 7.4); 0.15 M NaCl; and 0.3 mM EDTA (buffer A) (4) . Following dialysis, the lipoprotein-deficient fraction was defibrinated as previously reported (4) . Blood from a patient with abetalipoproteinemia (4) and from a normal subject was collected in EDTA (1 mg/ml), and the resulting plasma samples were coagulated with thrombin (4) and dialyzed against buffer A. Protein concentrations were determined by a modification of the method of Lowry, et al. (9) using bovine-serum albumin as a standard.
[1251]LDL. [125IILDL was prepared by Dr. David W. Bilheimer using a modification (10) of the iodine monochloride method of McFarlane (11). The final preparation, which was dialyzed into buffer A, contained less than 1 atom of iodine for each LDL molecule, and its final specific activity was 560 cpm/ng of protein. In this preparation, 99% of the radioactivity was precipitated by incubation with 15% trichloroacetic acid at 900, 95% was precipitated by monospecific goat antiserum to human LDL (Hyland), and 2% was extractable into chloroform: methanol (12) . When added to normal fibroblasts, this [125I]LDL preparation was able to suppress HMG CoA reductase activity in a manner similar to that of native LDL ( [251I]LDL Binding to Intact Fibroblasts. Cells were grown in dishes as described above, and on day 6 after 24-hr growth in medium containing lipoprotein-deficient serum, the medium was removed from each dish and replaced with 2 ml of solution consisting of Eagle's minimum essential medium; 20 mM tricine HCl, pH 7.4; and 2.5 mg/ml of lipoproteindeficient serum (buffer B) and the indicated amounts of [12IILDL and native LDL, which were added in a volume of buffer A varying from 2 to 150 Ml. After incubation for the indicated time either at 40 or 370, the medium was removed and all subsequent operations were carried out at 4°. Each cell monolayer was washed three times in rapid succession with 3 ml of buffer containing 50 mM Tris -HCl (pH 7.4); 0.15 M NaCl; and 2 mg/ml of bovine-serum albumin (buffer C), after which a further 3 ml of buffer C was added and the monolayer was incubated for 2 min. This latter step was repeated once, each monolayer was washed finally with 3 ml of buffer containing 50 mM Tris HCl (pH 7.4) and 0.15 M NaCl, and the cells were removed from the dish by dissolution in 1 ml of 0.1 N NaOH. Aliquots (500 gl and 50 Al, respectively) were removed from each dish for scintillation counting in a gamma counter and for measurement of protein concentration (9 (Fig. 2) .
In contrast to normal cells, fibroblasts from a homozygote with FH had virtually no detectable specific binding of [1ThIJ-LDL at either 40 or 370 at the LDL concentration used (Fig.   2 , right). Nonspecific binding (defined as the radioactivity bound in the presence of an excess of native LDL) was similar in the mutant and normal cells (Fig. 2) .
When the binding reaction was allowed to reach equilibrium at concentrations of LDL between 0 and 90 1ug/ml, specific binding of [125I]LDL to normal cells showed saturation kinetics (Fig. 3A, left) . At 370, saturation occurred at about 20 ,gg/ml of LDL, and half-maximal binding was observed in the range of 10 Ag/ml. By contrast, the nonspecific binding of ['251]LDL was not saturable and increased linearly with increasing amounts of LDL. At concentrations of LDL lower than 15 1ug/ml, the ratio of specific to nonspecific binding was about 10: 1. A Scatchard plot (16) of these data suggested the presence of a specific binding site of high affinity (Fig. 3B) while the apparent affinity was somewhat higher (Kd = 4.5 X 10-9 M), the maximum number of LDL molecules bound at 40 (7, (Fig. 3A, right) . However, nonspecific binding of LDL to these cells was similar to that of the normal. A Scatchard plot of these data confirmed the absence in the mutant cells of a high-affinity binding site for LDL (Fig. 3B) . The (3, 4) , sug- gested that specific binding of LDL is a necessary step in this regulatory process. This hypothesis was supported by the experiments in Fig. 4 , which show that when normal cells were incubated with LDL at a wide range of concentrations, the relative amount of binding was closely correlated with the relative degree of suppression of HMG CoA reductase activity.
Evidence that the observed '251-binding to normal cells is specific for LDL was obtained in experiments shown in Figs. 5 and 6. When the [125I]LDL preparation was preincubated with varying amounts of an antibody to LDL, increasing amounts of the radioactivity were precipitated (Fig. 5) . This resulted in a proportional decrease in the amount of radioactivity that could be bound specifically to the normal cells (Fig. 5) . The specificity of LDL binding was further shown by the observations that whole serum, LDL, and VLDL competed with [125I]LDL for binding, but that HDL and the lipoprotein-deficient fraction of serum (d > 1.215 g/ml) showed much less ability to displace LDL (Fig. 6A) . Since whole serum, LDL, and VLDL, but not HDL, contain apolipoprotein B (14) , these data suggest that this apolipoprotein is important in the binding of LDL to fibroblasts. Consistent with this hypothesis is the observation that serum On day 6 of cell growth, the medium was replaced with 2 ml of buffer B containing 5 ,g/ml of [125I]LDL either in the absence or presence of 500 uag/ml of native LDL. After incubation for 3 hr at either 40 or 370 the cell monolayers were washed and harvested as described in Materials and Methods. * The number in parentheses refers to the number of each subject in Table 1 from a patient with abetalipoproteinemia, which is devoid of apolipoprotein B (15) , was considerably less effective than normal serum in displacing [1251]LDL from its binding sites (Fig. 6B) .
The 125I radioactivity bound to the normal cells at either 40 or 37°remained associated with protein as determined by its complete precipitation by 15% trichloroacetic acid at 900. Only 2% of the bound radioactivity could be extracted by chloroform:methanol (12) . When containing unlabeled LDL and incubated at 37°, the radioactivity was released from the cells by a first-order process (Fig. 7) . This release of radioactivity was temperature-dependent (Fig. 7 ) and was associated with degradation of the [1251I]LDL molecule as determined by the fact that the majority of the released radioactivity was converted to a dialyzable form and less than 25% could be precipitated by either trichloroacetic acid or anti-LDL. The release of radioactivity from the cells at 40 and 370 was unaffected by the presence of levels of native LDL up to 500 Asg/ml and occurred equally in the absence or presence of lipoprotein-deficient serum. Proc. Nat. Acad. Sci. USA 71 (1974) 6 of cell growth, the medium was removed and the cell monolayers were incubated for 3 hr at 370 in 2 ml of fresh medium containing 20 mM tricine-HCl (pH 7.4), 10 6 of cell growth, the medium was removed and the cell monolayers were incubated at 40 in 2 ml of buffer B containing 5 ,ug/ml of [121I] LDL. After 3 hr, cell monolayers were washed as described in Materials and Methods and 2 ml of fresh buffer B containing 5 jg/ml of native LDL was added (0 time). Cells were then incubated at either 40 (0) or 370 (0) and at the indicated time the medium was removed, the cell monolayers were washed once with 2 ml of chilled buffer containing 50 mM Tris HCl (pH 7.4) and 0.15 M NaCl, and dissolved in 0.1 N NaOH for measurement of the remaining radioactivity as described in Materials and Methods.
indicated by three observations: (i) the degree of suppression of HMG CoA reductase activity is proportional to the amount of LDL bound; (ii) VLDL, which also suppresses enzyme activity (4) , is able to compete with LDL for binding, whereas HDL, the lipoprotein-deficient fraction of normal serum, and abetalipoproteinemic serum, which do not suppress enzyme activity (4), do not compete effectively for binding; and (iii) cells from homozygotes with FH, which are resistant to LDI-mediated suppression of HMG CoA reductase activity, are also deficient in specific LDL binding.
Although binding of [1251 ] LDL to normal intact fibroblasts appears to represent an interaction of LDL with a physiological "receptor," the molecular mechanism by which binding leads to suppression of synthesis of HMG CoA reductase molecules is not yet known. Further studies are necessary to determine whether binding of lipoproteins to the cell surface is sufficient in itself to achieve this physiological effect or whether there is an additional requirement for cellular entry of intact LDL or one of its components. The product of the temperature-dependent degradation of bound LDL and its physiological significance also remains to be explored.
The defect in high-affinity LDL binding observed in the cells of homozygotes with FH appears to explain our earlier findings of elevated HMG CoA reductase activity (3, 4) and cholesterol overproduction in these cultured cells (3) . Thus, the binding defect may represent the primary genetic lesion in this disorder.
